Haem Rahimi, Muzhda
Bidar, Frank
Lukaszewicz, Anne-Claire
Garnier, Lorna
Payen-Gay, Léa
Venet, Fabienne
Monneret, Guillaume http://orcid.org/0000-0002-9961-5739
Funding for this research was provided by:
Fondation Hospices Civils de Lyon
Article History
Received: 10 July 2023
Accepted: 11 October 2023
First Online: 17 October 2023
Declarations
:
: The patients belonged to the IMMUNOSEPSIS study registered at clinicaltrials.gov (NCT04067674). Because of the non-interventional nature of the study, written informed consent was not required for inclusion. However, each clinician orally informed the patient or family members about the objectives, methodology, and conduct of the study, and provided them with a leaflet using plain language. Non opposition to participation to this study was systematically obtained from the patient or a third party before any blood sampling was performed and was recorded in patient’s clinical file. All procedures performed were in accordance with the ethical standards of the institutional and/or national research committee (Comité de Protection des Personnes Ouest II, IRB number #19.01.23.71957) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Not applicable.
: The authors declare they have no conflict of interest.